Literature DB >> 6778574

Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction.

A D Timmis, M B Fowler, D A Chamberlain.   

Abstract

Twelve patients with severe persistent cardiogenic shock complicating acute myocardial infarction underwent single crossover treatment with intravenous dopamine and salbutamol to determine the more beneficial therapy. Salbutamol (10 to 40 microgram/min) reduced systemic vascular resistance and progressively increased both cardiac index and stroke index. Heart rate increased from 95 to 104 beats/min. Changes in mean arterial pressure and pulmonary artery end-diastolic pressure were small and insignificant. Dopamine infusion at rates of 200 and 400 micrograms/min also increased cardiac index and stroke index. Systemic vascular resistance fell slightly but mean arterial pressure rose from 57 to 65 mm Hg. Heart rate increased from 95 to 105 beats/min. Changes in pulmonary artery end-diastolic pressure were again small and insignificant. Dopamine infusion at 800 micrograms/min caused an appreciable increase in systemic vascular resistance; a further increment in mean arterial pressure was observed, though cardiac index fell slightly. Heart rate and pulmonary artery end-diastolic pressure rose steeply. Salbutamol, a vasodilator, increased cardiac output in patients with cardiogenic shock complicating acute myocardial infarction but did not influence blood pressure. If correction of hypotension is essential dopamine in low doses may be the preferred agent. Doses of 800 microgram/min, which is within the therapeutic range, worsen other manifestations of left ventricular dysfunction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6778574      PMCID: PMC1503758          DOI: 10.1136/bmj.282.6257.7

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  17 in total

1.  Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis.

Authors:  K Chatterjee; H J Swan; V S Kaushik; G Jobin; P Magnusson; J S Forrester
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

2.  Effectiveness of dopamine in patients with cardiogenic shock.

Authors:  J Holzer; J S Karliner; R A O'Rourke; W Pitt; J Ross
Journal:  Am J Cardiol       Date:  1973-07       Impact factor: 2.778

3.  Acute hemodynamic effects of dopamine in patients with shock.

Authors:  H S Loeb; E B Winslow; S H Rahimtoola; K M Rosen; R M Gunnar
Journal:  Circulation       Date:  1971-08       Impact factor: 29.690

4.  Cardiogenic shock. Myocardial morphology with and without artificial left ventricular counterpulsation.

Authors:  J B Caulfield; W B Dunkman; R C Leinbach
Journal:  Arch Pathol       Date:  1972-06

5.  A hemodynamic comparison of dopamine and isoproterenol in patients in shock.

Authors:  R C Talley; L I Goldberg; C E Johnson; J L McNay
Journal:  Circulation       Date:  1969-03       Impact factor: 29.690

6.  Effects and mechanisms of action of dopamine on regional hemodynamics in the conscious dog.

Authors:  C B Higgins; R W Millard; E Braunwald; S F Vatner
Journal:  Am J Physiol       Date:  1973-08

7.  Cardiac effects of beta-adrenergic receptor antagonists.

Authors:  B Ablad; B Carlsson; E Carlsson; C Dahlöf; L Ek; E Hultberg
Journal:  Adv Cardiol       Date:  1974

8.  Dopamine in the treatment of hypotension and shock.

Authors:  K L MacCannell; J L McNay; M B Meyer; L I Goldberg
Journal:  N Engl J Med       Date:  1966-12-22       Impact factor: 91.245

9.  Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.

Authors:  C V Leier; P T Heban; P Huss; C A Bush; R P Lewis
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

10.  Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.

Authors:  D R Stemple; J H Kleiman; D C Harrison
Journal:  Am J Cardiol       Date:  1978-08       Impact factor: 2.778

View more
  8 in total

1.  Delays and diversity in the practice of local research ethics committees.

Authors:  A H Ahmed; K G Nicholson
Journal:  J Med Ethics       Date:  1996-10       Impact factor: 2.903

Review 2.  Cardiogenic shock.

Authors:  C E Handler
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

Review 3.  Vasodilators in acute circulatory failure.

Authors:  C Blakeley; J Tinker
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

4.  Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction.

Authors:  M B Fowler; A D Timmis; J P Crick; R Vincent; D A Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

5.  The effects of dopexamine on the cardiovascular system of the dog.

Authors:  R A Brown; J B Farmer; J C Hall; R G Humphries; S E O'Connor; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

6.  Cardiogenic shock without a critically raised left ventricular end diastolic pressure: management and outcome in eighteen patients.

Authors:  D Edwards; S Whittaker; A Prior
Journal:  Br Heart J       Date:  1986-06

7.  Vasoactive pharmacologic therapy in cardiogenic shock: a critical review.

Authors:  Rasha Kaddoura; Amr Elmoheen; Ehab Badawy; Mahmoud F Eltawagny; Mohamed A Seif; Khalid Bashir; Amar M Salam
Journal:  J Drug Assess       Date:  2021-07-20

8.  Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Andrew M Harrison; Perliveh Carrera; Narat Srivali; Wonngarm Kittamongkolchai; Aysen Erdogan; Kianoush B Kashani
Journal:  BMC Pharmacol Toxicol       Date:  2016-05-07       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.